Prospective, randomized, double-blind, controlled, parallel-group, multi-site, interventional Phase III trial to evaluate efficacy and safety of two doses of a fixed dose combination of Tramadol and Diclofenac in acute pain
Latest Information Update: 16 Jun 2019
At a glance
- Drugs Diclofenac/tramadol (Primary)
- Indications Acute pain
- Focus Therapeutic Use
Most Recent Events
- 16 Jun 2019 New trial record
- 06 Apr 2019 Primary end point (Total pain relief after 4 hours (TOTPAR4) has been met